4
Changes in Ownership
ADMA BIOLOGICS, INC. Filed Acc 0001140361-23-010774
President and CEO gave up 49,544 shares (to pay taxes)
- President and CEO acquired 573,695 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Grossman Adam S President and CEO | 2023-02-25 | Shares withheld for taxes | −4,018 | $3.42 | $13,742 | 2,032,823 | D |
| Grossman Adam S President and CEO | 2023-02-25 | Shares withheld for taxes | −14,412 | $3.42 | $49,289 | 2,018,411 | D |
| Grossman Adam S President and CEO | 2023-02-28 | Shares withheld for taxes | −7,507 | $3.55 | $26,650 | 2,010,904 | D |
| Grossman Adam S President and CEO | 2023-03-06 | Grant or award | +573,695 | 2,584,599 | D | ||
| Grossman Adam S President and CEO | 2023-03-07 | Shares withheld for taxes | −23,607 | $3.40 | $80,264 | 2,560,992 | D |
| Derivatives | |||||||
| Grossman Adam S President and CEO | 2023-03-06 | Grant or award · Employee Stock Option (right to buy) | +1,147,385 | 1,147,385 | D | ||
Loading xslF345X03/form4.xml…